Methods such as the use of zinc-finger proteins and dCas9 to modify chromatin structures or manipulate specific enhancer–promoter interactions have been reported [46,47,48,49], indicating the potential to treat cancer by focusing on 3D chromatin structures. Here, ZNF146 is linked to cancer.